{"transactions":[{"id":1424353,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-08-23T16:27:19.000Z","date":"2024-08-22","kind":"sale","planned":true,"acquired":false,"shares":26922,"price":4.4974,"value":121079.0028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $4.415 to $4.62, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":139365,"source":{"system":"sec-edgar","filing":"0001062993-24-015606","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000106299324015606/form4.xml","form_type":"4"}},{"id":1591913,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-06T19:42:58.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":60010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":60010,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":60010},"source":{"system":"sec-edgar","filing":"0001062993-24-005766","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000106299324005766/form4.xml","form_type":"4"}},{"id":1591912,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-03-06T19:42:58.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":6609,"price":3.44,"value":22734.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":166287,"source":{"system":"sec-edgar","filing":"0001062993-24-005766","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000106299324005766/form4.xml","form_type":"4"}},{"id":1591911,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-03-06T19:42:58.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":6772,"price":3.43,"value":23227.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":172896,"source":{"system":"sec-edgar","filing":"0001062993-24-005766","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000106299324005766/form4.xml","form_type":"4"}},{"id":1591910,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2024-03-06T19:42:58.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":39990,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":179668,"source":{"system":"sec-edgar","filing":"0001062993-24-005766","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000106299324005766/form4.xml","form_type":"4"}},{"id":1963413,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-08T20:04:08.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":128599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":128599,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":128599},"source":{"system":"sec-edgar","filing":"0001062993-23-006328","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000106299323006328/form4.xml","form_type":"4"}},{"id":1963412,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-03-08T20:04:08.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":13387,"price":8.6,"value":115128.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to $8.89, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":139678,"source":{"system":"sec-edgar","filing":"0001062993-23-006328","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000106299323006328/form4.xml","form_type":"4"}},{"id":1963411,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-03-08T20:04:08.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":5491,"price":8.57,"value":47057.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":153065,"source":{"system":"sec-edgar","filing":"0001062993-23-006328","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000106299323006328/form4.xml","form_type":"4"}},{"id":1963410,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2023-03-08T20:04:08.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":85697,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":158556,"source":{"system":"sec-edgar","filing":"0001062993-23-006328","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000106299323006328/form4.xml","form_type":"4"}},{"id":2339961,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-03-10T21:00:16.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":2387,"price":11.44,"value":27307.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $11.32 to 11.65, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":72859,"source":{"system":"sec-edgar","filing":"0001209191-22-018095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919122018095/doc4.xml","form_type":"4"}},{"id":2344804,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-08T21:00:58.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":154448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":154448,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":154448},"source":{"system":"sec-edgar","filing":"0001209191-22-017397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919122017397/doc4.xml","form_type":"4"}},{"id":2344803,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-03-08T21:00:58.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":1569,"price":12.01,"value":18843.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":75246,"source":{"system":"sec-edgar","filing":"0001209191-22-017397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919122017397/doc4.xml","form_type":"4"}},{"id":2344802,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-03-08T21:00:58.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":61779,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":76815,"source":{"system":"sec-edgar","filing":"0001209191-22-017397","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919122017397/doc4.xml","form_type":"4"}},{"id":2459692,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-23T21:00:32.000Z","date":"2021-12-22","kind":"exercise","acquired":false,"shares":5208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":17709,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":5208},"source":{"system":"sec-edgar","filing":"0001209191-21-071194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121071194/doc4.xml","form_type":"4"}},{"id":2459691,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-23T21:00:32.000Z","date":"2021-12-22","kind":"exercise","acquired":false,"shares":10130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":5313,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":10130},"source":{"system":"sec-edgar","filing":"0001209191-21-071194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121071194/doc4.xml","form_type":"4"}},{"id":2459690,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-12-23T21:00:32.000Z","date":"2021-12-22","kind":"sale","acquired":false,"shares":15338,"price":30,"value":460140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021."}],"balance_after":15036,"source":{"system":"sec-edgar","filing":"0001209191-21-071194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121071194/doc4.xml","form_type":"4"}},{"id":2459689,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-12-23T21:00:32.000Z","date":"2021-12-22","kind":"exercise","acquired":true,"shares":5208,"price":7.8,"value":40622.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021."}],"balance_after":30374,"source":{"system":"sec-edgar","filing":"0001209191-21-071194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121071194/doc4.xml","form_type":"4"}},{"id":2459688,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-12-23T21:00:32.000Z","date":"2021-12-22","kind":"exercise","acquired":true,"shares":10130,"price":6.55,"value":66351.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021."}],"balance_after":25166,"source":{"system":"sec-edgar","filing":"0001209191-21-071194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121071194/doc4.xml","form_type":"4"}},{"id":2574867,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-09T19:00:15.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":15443,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":495},"source":{"system":"sec-edgar","filing":"0001209191-21-055367","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121055367/doc4.xml","form_type":"4"}},{"id":2574866,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-09-09T19:00:15.000Z","date":"2021-09-07","kind":"sale","acquired":false,"shares":495,"price":40,"value":19800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":15036,"source":{"system":"sec-edgar","filing":"0001209191-21-055367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121055367/doc4.xml","form_type":"4"}},{"id":2574865,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-09-09T19:00:15.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":495,"price":6.55,"value":3242.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":15531,"source":{"system":"sec-edgar","filing":"0001209191-21-055367","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121055367/doc4.xml","form_type":"4"}},{"id":2647919,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T21:00:20.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":1354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":43334,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":1354},"source":{"system":"sec-edgar","filing":"0001209191-21-044630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121044630/doc4.xml","form_type":"4"}},{"id":2647918,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T21:00:20.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":1771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":15938,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":1771},"source":{"system":"sec-edgar","filing":"0001209191-21-044630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121044630/doc4.xml","form_type":"4"}},{"id":2647917,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T21:00:20.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":22917,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1042},"source":{"system":"sec-edgar","filing":"0001209191-21-044630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121044630/doc4.xml","form_type":"4"}},{"id":2647916,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-07-01T21:00:20.000Z","date":"2021-06-30","kind":"sale","acquired":false,"shares":395,"price":42.13,"value":16641.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":15036,"source":{"system":"sec-edgar","filing":"0001209191-21-044630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121044630/doc4.xml","form_type":"4"}},{"id":2647915,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-07-01T21:00:20.000Z","date":"2021-06-30","kind":"sale","acquired":false,"shares":3772,"price":41.35,"value":155972.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $41.00 to 41.58, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":15431,"source":{"system":"sec-edgar","filing":"0001209191-21-044630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121044630/doc4.xml","form_type":"4"}},{"id":2647914,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-07-01T21:00:20.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":1354,"price":31.71,"value":42935.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":19203,"source":{"system":"sec-edgar","filing":"0001209191-21-044630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121044630/doc4.xml","form_type":"4"}},{"id":2647913,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-07-01T21:00:20.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":1771,"price":6.55,"value":11600.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":17849,"source":{"system":"sec-edgar","filing":"0001209191-21-044630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121044630/doc4.xml","form_type":"4"}},{"id":2647912,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-07-01T21:00:20.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":1042,"price":7.8,"value":8127.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":16078,"source":{"system":"sec-edgar","filing":"0001209191-21-044630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121044630/doc4.xml","form_type":"4"}},{"id":2661349,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T20:00:50.000Z","date":"2021-06-17","kind":"exercise","acquired":false,"shares":1354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":44688,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":1354},"source":{"system":"sec-edgar","filing":"0001209191-21-042291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121042291/doc4.xml","form_type":"4"}},{"id":2661348,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T20:00:50.000Z","date":"2021-06-17","kind":"exercise","acquired":false,"shares":1771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":17709,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":1771},"source":{"system":"sec-edgar","filing":"0001209191-21-042291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121042291/doc4.xml","form_type":"4"}},{"id":2661347,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T20:00:50.000Z","date":"2021-06-17","kind":"exercise","acquired":false,"shares":1041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":23959,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1041},"source":{"system":"sec-edgar","filing":"0001209191-21-042291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121042291/doc4.xml","form_type":"4"}},{"id":2661346,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-06-21T20:00:50.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":4166,"price":40,"value":166640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":15036,"source":{"system":"sec-edgar","filing":"0001209191-21-042291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121042291/doc4.xml","form_type":"4"}},{"id":2661345,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-06-21T20:00:50.000Z","date":"2021-06-17","kind":"exercise","acquired":true,"shares":1354,"price":31.71,"value":42935.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":19202,"source":{"system":"sec-edgar","filing":"0001209191-21-042291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121042291/doc4.xml","form_type":"4"}},{"id":2661344,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-06-21T20:00:50.000Z","date":"2021-06-17","kind":"exercise","acquired":true,"shares":1771,"price":6.55,"value":11600.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":17848,"source":{"system":"sec-edgar","filing":"0001209191-21-042291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121042291/doc4.xml","form_type":"4"}},{"id":2661343,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-06-21T20:00:50.000Z","date":"2021-06-17","kind":"exercise","acquired":true,"shares":1041,"price":7.8,"value":8119.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":16077,"source":{"system":"sec-edgar","filing":"0001209191-21-042291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121042291/doc4.xml","form_type":"4"}},{"id":2733127,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-03T19:00:21.000Z","date":"2021-04-30","kind":"exercise","acquired":false,"shares":1354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":46042,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":1354},"source":{"system":"sec-edgar","filing":"0001209191-21-029626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121029626/doc4.xml","form_type":"4"}},{"id":2733126,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-03T19:00:21.000Z","date":"2021-04-30","kind":"exercise","acquired":false,"shares":1770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":19480,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":1770},"source":{"system":"sec-edgar","filing":"0001209191-21-029626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121029626/doc4.xml","form_type":"4"}},{"id":2733125,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-03T19:00:21.000Z","date":"2021-04-30","kind":"exercise","acquired":false,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":25000,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1042},"source":{"system":"sec-edgar","filing":"0001209191-21-029626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121029626/doc4.xml","form_type":"4"}},{"id":2733124,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-05-03T19:00:21.000Z","date":"2021-04-30","kind":"sale","acquired":false,"shares":4166,"price":41.93,"value":174680.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $41.68 to 42.14, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":15036,"source":{"system":"sec-edgar","filing":"0001209191-21-029626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121029626/doc4.xml","form_type":"4"}},{"id":2733123,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-05-03T19:00:21.000Z","date":"2021-04-30","kind":"exercise","acquired":true,"shares":1354,"price":31.71,"value":42935.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":19202,"source":{"system":"sec-edgar","filing":"0001209191-21-029626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121029626/doc4.xml","form_type":"4"}},{"id":2733122,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-05-03T19:00:21.000Z","date":"2021-04-30","kind":"exercise","acquired":true,"shares":1770,"price":6.55,"value":11593.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":17848,"source":{"system":"sec-edgar","filing":"0001209191-21-029626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121029626/doc4.xml","form_type":"4"}},{"id":2733121,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-05-03T19:00:21.000Z","date":"2021-04-30","kind":"exercise","acquired":true,"shares":1042,"price":7.8,"value":8127.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":16078,"source":{"system":"sec-edgar","filing":"0001209191-21-029626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121029626/doc4.xml","form_type":"4"}},{"id":2761590,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T21:00:11.000Z","date":"2021-03-31","kind":"exercise","acquired":false,"shares":1354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":47396,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":1354},"source":{"system":"sec-edgar","filing":"0001209191-21-024893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121024893/doc4.xml","form_type":"4"}},{"id":2761589,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T21:00:11.000Z","date":"2021-03-31","kind":"exercise","acquired":false,"shares":1771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":21250,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":1771},"source":{"system":"sec-edgar","filing":"0001209191-21-024893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121024893/doc4.xml","form_type":"4"}},{"id":2761588,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T21:00:11.000Z","date":"2021-03-31","kind":"exercise","acquired":false,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":26042,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1042},"source":{"system":"sec-edgar","filing":"0001209191-21-024893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121024893/doc4.xml","form_type":"4"}},{"id":2761587,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-04-02T21:00:11.000Z","date":"2021-03-31","kind":"sale","acquired":false,"shares":4167,"price":40,"value":166680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":15036,"source":{"system":"sec-edgar","filing":"0001209191-21-024893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121024893/doc4.xml","form_type":"4"}},{"id":2761586,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-04-02T21:00:11.000Z","date":"2021-03-31","kind":"exercise","acquired":true,"shares":1354,"price":31.71,"value":42935.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":19203,"source":{"system":"sec-edgar","filing":"0001209191-21-024893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121024893/doc4.xml","form_type":"4"}},{"id":2761585,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-04-02T21:00:11.000Z","date":"2021-03-31","kind":"exercise","acquired":true,"shares":1771,"price":6.55,"value":11600.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":17849,"source":{"system":"sec-edgar","filing":"0001209191-21-024893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121024893/doc4.xml","form_type":"4"}},{"id":2761584,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-04-02T21:00:11.000Z","date":"2021-03-31","kind":"exercise","acquired":true,"shares":1042,"price":7.8,"value":8127.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":16078,"source":{"system":"sec-edgar","filing":"0001209191-21-024893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121024893/doc4.xml","form_type":"4"}},{"id":2803439,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-08T19:00:33.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":34341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest with respect to 1/4 of such shares on March 4, 2022, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":34341,"derivative":{"exercise_price":43.68,"expiration_date":"2021-03-04","underlying":"Common Stock","underlying_shares":34341},"source":{"system":"sec-edgar","filing":"0001209191-21-018743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121018743/doc4.xml","form_type":"4"}},{"id":2803438,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-03-08T19:00:33.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":13736,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15036,"source":{"system":"sec-edgar","filing":"0001209191-21-018743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121018743/doc4.xml","form_type":"4"}},{"id":2826865,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-01T20:00:33.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":1771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":23021,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":1771},"source":{"system":"sec-edgar","filing":"0001209191-21-015471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121015471/doc4.xml","form_type":"4"}},{"id":2826864,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-01T20:00:33.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":1041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":27084,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1041},"source":{"system":"sec-edgar","filing":"0001209191-21-015471","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121015471/doc4.xml","form_type":"4"}},{"id":2826863,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-03-01T20:00:33.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":1333,"price":56.4,"value":75181.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $56.01 to 56.66, inclusive."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001209191-21-015471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121015471/doc4.xml","form_type":"4"}},{"id":2826862,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-03-01T20:00:33.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":400,"price":55.46,"value":22184.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $55.025 to 55.66, inclusive."}],"balance_after":2633,"source":{"system":"sec-edgar","filing":"0001209191-21-015471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121015471/doc4.xml","form_type":"4"}},{"id":2826861,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-03-01T20:00:33.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":1079,"price":54.47,"value":58773.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $54.00 to 54.855, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":3033,"source":{"system":"sec-edgar","filing":"0001209191-21-015471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121015471/doc4.xml","form_type":"4"}},{"id":2826860,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-03-01T20:00:33.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":1771,"price":6.55,"value":11600.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":4112,"source":{"system":"sec-edgar","filing":"0001209191-21-015471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121015471/doc4.xml","form_type":"4"}},{"id":2826859,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-03-01T20:00:33.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":1041,"price":7.8,"value":8119.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":2341,"source":{"system":"sec-edgar","filing":"0001209191-21-015471","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121015471/doc4.xml","form_type":"4"}},{"id":2855221,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T20:01:11.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":48750,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":16250},"source":{"system":"sec-edgar","filing":"0001209191-21-011548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121011548/doc4.xml","form_type":"4"}},{"id":2855220,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-02-17T20:01:11.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":9256,"price":65.29,"value":604324.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $65.00 to 65.67, inclusive."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001209191-21-011548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121011548/doc4.xml","form_type":"4"}},{"id":2855219,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-02-17T20:01:11.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":2100,"price":64.56,"value":135576.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $64.00 to 64.98, inclusive."}],"balance_after":10556,"source":{"system":"sec-edgar","filing":"0001209191-21-011548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121011548/doc4.xml","form_type":"4"}},{"id":2855218,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-02-17T20:01:11.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":4894,"price":63.43,"value":310426.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $63.00 to 63.995, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":12656,"source":{"system":"sec-edgar","filing":"0001209191-21-011548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121011548/doc4.xml","form_type":"4"}},{"id":2855217,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-02-17T20:01:11.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":16250,"price":31.71,"value":515287.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":17550,"source":{"system":"sec-edgar","filing":"0001209191-21-011548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121011548/doc4.xml","form_type":"4"}},{"id":2888838,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-01T20:00:17.000Z","date":"2021-01-29","kind":"exercise","acquired":false,"shares":1771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":24792,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":1771},"source":{"system":"sec-edgar","filing":"0001209191-21-006578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121006578/doc4.xml","form_type":"4"}},{"id":2888837,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-01T20:00:17.000Z","date":"2021-01-29","kind":"exercise","acquired":false,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":28125,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1042},"source":{"system":"sec-edgar","filing":"0001209191-21-006578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121006578/doc4.xml","form_type":"4"}},{"id":2888836,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-02-01T20:00:17.000Z","date":"2021-01-29","kind":"sale","acquired":false,"shares":628,"price":57.76,"value":36273.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $57.46 to 58.18, inclusive."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001209191-21-006578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121006578/doc4.xml","form_type":"4"}},{"id":2888835,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-02-01T20:00:17.000Z","date":"2021-01-29","kind":"sale","acquired":false,"shares":1090,"price":56.59,"value":61683.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $56.34 to 57.12, inclusive."}],"balance_after":1928,"source":{"system":"sec-edgar","filing":"0001209191-21-006578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121006578/doc4.xml","form_type":"4"}},{"id":2888834,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-02-01T20:00:17.000Z","date":"2021-01-29","kind":"sale","acquired":false,"shares":1095,"price":55.71,"value":61002.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $55.17 to 56.00, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":3018,"source":{"system":"sec-edgar","filing":"0001209191-21-006578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121006578/doc4.xml","form_type":"4"}},{"id":2888833,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-02-01T20:00:17.000Z","date":"2021-01-29","kind":"exercise","acquired":true,"shares":1771,"price":6.55,"value":11600.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":4113,"source":{"system":"sec-edgar","filing":"0001209191-21-006578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121006578/doc4.xml","form_type":"4"}},{"id":2888832,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-02-01T20:00:17.000Z","date":"2021-01-29","kind":"exercise","acquired":true,"shares":1042,"price":7.8,"value":8127.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":2342,"source":{"system":"sec-edgar","filing":"0001209191-21-006578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919121006578/doc4.xml","form_type":"4"}},{"id":2927848,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-31T21:00:08.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":1771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":26563,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":1771},"source":{"system":"sec-edgar","filing":"0001209191-20-065774","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120065774/doc4.xml","form_type":"4"}},{"id":2927847,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-31T21:00:08.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":4759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":29167,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":4759},"source":{"system":"sec-edgar","filing":"0001209191-20-065774","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120065774/doc4.xml","form_type":"4"}},{"id":2927846,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-12-31T21:00:08.000Z","date":"2020-12-31","kind":"sale","acquired":false,"shares":391,"price":59.27,"value":23174.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001209191-20-065774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120065774/doc4.xml","form_type":"4"}},{"id":2927845,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-12-31T21:00:08.000Z","date":"2020-12-31","kind":"sale","acquired":false,"shares":1610,"price":58.4,"value":94024.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $58.06 to 59.01, inclusive."}],"balance_after":1691,"source":{"system":"sec-edgar","filing":"0001209191-20-065774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120065774/doc4.xml","form_type":"4"}},{"id":2927844,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-12-31T21:00:08.000Z","date":"2020-12-31","kind":"sale","acquired":false,"shares":4529,"price":57.54,"value":260598.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $57.05 to 58.01, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":3301,"source":{"system":"sec-edgar","filing":"0001209191-20-065774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120065774/doc4.xml","form_type":"4"}},{"id":2927843,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-12-31T21:00:08.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":1771,"price":6.55,"value":11600.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":7830,"source":{"system":"sec-edgar","filing":"0001209191-20-065774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120065774/doc4.xml","form_type":"4"}},{"id":2927842,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-12-31T21:00:08.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":4759,"price":7.8,"value":37120.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 23, 2020."}],"balance_after":6059,"source":{"system":"sec-edgar","filing":"0001209191-20-065774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120065774/doc4.xml","form_type":"4"}},{"id":2968368,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-24T20:00:14.000Z","date":"2020-11-23","kind":"exercise","acquired":false,"shares":1771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":28334,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":1771},"source":{"system":"sec-edgar","filing":"0001209191-20-060395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120060395/doc4.xml","form_type":"4"}},{"id":2968367,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-24T20:00:14.000Z","date":"2020-11-23","kind":"exercise","acquired":false,"shares":1109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":33926,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1109},"source":{"system":"sec-edgar","filing":"0001209191-20-060395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120060395/doc4.xml","form_type":"4"}},{"id":2968366,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-11-24T20:00:14.000Z","date":"2020-11-23","kind":"sale","acquired":false,"shares":2857,"price":46.31,"value":132307.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $46.02 to 46.79, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001209191-20-060395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120060395/doc4.xml","form_type":"4"}},{"id":2968365,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-11-24T20:00:14.000Z","date":"2020-11-23","kind":"sale","acquired":false,"shares":23,"price":45.69,"value":1050.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":4157,"source":{"system":"sec-edgar","filing":"0001209191-20-060395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120060395/doc4.xml","form_type":"4"}},{"id":2968364,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-11-24T20:00:14.000Z","date":"2020-11-23","kind":"exercise","acquired":true,"shares":1771,"price":6.55,"value":11600.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":4180,"source":{"system":"sec-edgar","filing":"0001209191-20-060395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120060395/doc4.xml","form_type":"4"}},{"id":2968363,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-11-24T20:00:14.000Z","date":"2020-11-23","kind":"exercise","acquired":true,"shares":1109,"price":7.8,"value":8650.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":2409,"source":{"system":"sec-edgar","filing":"0001209191-20-060395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120060395/doc4.xml","form_type":"4"}},{"id":2998743,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-28T19:00:10.000Z","date":"2020-10-26","kind":"exercise","acquired":false,"shares":1770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":30105,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":1770},"source":{"system":"sec-edgar","filing":"0001209191-20-056137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120056137/doc4.xml","form_type":"4"}},{"id":2998742,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-28T19:00:10.000Z","date":"2020-10-26","kind":"exercise","acquired":false,"shares":1110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":35035,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1110},"source":{"system":"sec-edgar","filing":"0001209191-20-056137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120056137/doc4.xml","form_type":"4"}},{"id":2998741,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-28T19:00:10.000Z","date":"2020-10-26","kind":"sale","acquired":false,"shares":2262,"price":49.96,"value":113009.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $49.41 to 50.39, inclusive."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001209191-20-056137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120056137/doc4.xml","form_type":"4"}},{"id":2998740,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-28T19:00:10.000Z","date":"2020-10-26","kind":"sale","acquired":false,"shares":618,"price":49.11,"value":30349.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $48.64 to 49.36, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":3562,"source":{"system":"sec-edgar","filing":"0001209191-20-056137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120056137/doc4.xml","form_type":"4"}},{"id":2998739,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-28T19:00:10.000Z","date":"2020-10-26","kind":"exercise","acquired":true,"shares":1770,"price":6.55,"value":11593.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":4180,"source":{"system":"sec-edgar","filing":"0001209191-20-056137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120056137/doc4.xml","form_type":"4"}},{"id":2998738,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-10-28T19:00:10.000Z","date":"2020-10-26","kind":"exercise","acquired":true,"shares":1110,"price":7.8,"value":8658.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":2410,"source":{"system":"sec-edgar","filing":"0001209191-20-056137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120056137/doc4.xml","form_type":"4"}},{"id":3021750,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-28T20:00:10.000Z","date":"2020-09-24","kind":"exercise","acquired":false,"shares":1771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":31875,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":1771},"source":{"system":"sec-edgar","filing":"0001209191-20-052268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120052268/doc4.xml","form_type":"4"}},{"id":3021749,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-28T20:00:10.000Z","date":"2020-09-24","kind":"exercise","acquired":false,"shares":1109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":36145,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1109},"source":{"system":"sec-edgar","filing":"0001209191-20-052268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120052268/doc4.xml","form_type":"4"}},{"id":3021748,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-09-28T20:00:10.000Z","date":"2020-09-24","kind":"sale","acquired":false,"shares":596,"price":48.49,"value":28900.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $48.03 to 48.69, inclusive."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001209191-20-052268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120052268/doc4.xml","form_type":"4"}},{"id":3021747,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-09-28T20:00:10.000Z","date":"2020-09-24","kind":"sale","acquired":false,"shares":2284,"price":47.59,"value":108695.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $47.31 to 47.93, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1896,"source":{"system":"sec-edgar","filing":"0001209191-20-052268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120052268/doc4.xml","form_type":"4"}},{"id":3021746,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-09-28T20:00:10.000Z","date":"2020-09-24","kind":"exercise","acquired":true,"shares":1771,"price":6.55,"value":11600.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":4180,"source":{"system":"sec-edgar","filing":"0001209191-20-052268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120052268/doc4.xml","form_type":"4"}},{"id":3021745,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-09-28T20:00:10.000Z","date":"2020-09-24","kind":"exercise","acquired":true,"shares":1109,"price":7.8,"value":8650.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."}],"balance_after":2409,"source":{"system":"sec-edgar","filing":"0001209191-20-052268","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120052268/doc4.xml","form_type":"4"}},{"id":3048905,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-24T20:00:49.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":1771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":33646,"derivative":{"exercise_price":6.55,"expiration_date":"2028-04-24","underlying":"Common Stock","underlying_shares":1771},"source":{"system":"sec-edgar","filing":"0001209191-20-048165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120048165/doc4.xml","form_type":"4"}},{"id":3048904,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-24T20:00:49.000Z","date":"2020-08-24","kind":"exercise","acquired":false,"shares":1109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":37254,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1109},"source":{"system":"sec-edgar","filing":"0001209191-20-048165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120048165/doc4.xml","form_type":"4"}},{"id":3048903,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-08-24T20:00:49.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":220,"price":43.36,"value":9539.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $43.31 to 43.80, inclusive."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001209191-20-048165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120048165/doc4.xml","form_type":"4"}},{"id":3048902,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":88047,"kind":"person","name":"Taylor Stacy L","position":1,"cik":"0001799081","reported_name":"Taylor Stacy L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2020-08-24T20:00:49.000Z","date":"2020-08-24","kind":"sale","acquired":false,"shares":1400,"price":42.92,"value":60088.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $42.46 to 43.23, inclusive."}],"balance_after":1520,"source":{"system":"sec-edgar","filing":"0001209191-20-048165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1799081/000120919120048165/doc4.xml","form_type":"4"}}],"next_cursor":"2020-08-24T20:00:49.000000Z,3048902"}